首頁 > 市場調查報告書 > 製藥

癌症

市場調查報告書

商品編碼

1424998

胰臟癌治療和診斷市場，按治療類型、診斷、最終用戶、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Pancreatic Cancer Therapeutics & Diagnostics Market, By Treatment Type, Diagnostic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: 2024年02月07日 | 出版商:

AnalystView Market Insights | 英文 290 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2022年胰臟癌治療和診斷市場規模為 24.706 億美元，2023年至2030年複合CAGR為 5.5%。

胰臟癌治療與診斷市場-市場動態

胰臟癌發病率的上升、分子生物學、藥物開發和診斷技術的進步預計將推動市場需求

市場成長是由胰臟癌發病率上升、分子生物學、藥物開發和診斷技術的進步等因素所推動的。由於研發措施的增加、有利的償付方案以及創新產品的推出，市場可望大幅擴張。值得注意的是，2019年1月，Van Andel 研究所的科學家推出了一種新型血液檢測（CA19-9 檢測），與現有檢測相結合，可以檢測出近70%的胰腺癌，假陽性率低於5%。此外，Myriad Genetics Inc. 於2021年 1月宣布，其用於胰腺癌篩檢的 BRACAnalysis 診斷系統將獲得日本厚生勞動省的補償，這可能會擴大日本基因檢測的患者群體。積極塑造市場。2020年10月，Oncolytics Biotech Inc.揭露了與羅氏和AIO合作進行的一項1/2期試驗，評估pelareorep和atezolizumab治療轉移性胰臟癌的療效。預計這些發展將對整個預測期內的市場成長產生有利影響。

胰臟癌治療和診斷市場 - 關鍵見解

根據研究分析師的分析，預計全球胰腺癌治療和診斷市場在預測期內（2023-2030年）每年將以 5.5%左右的CAGR成長

由於胰臟癌發病率上升、分子生物學、藥物開發和診斷技術的進步，癌症治療和診斷市場預計將以顯著的速度成長

根據最終用戶，預計醫院在2022年顯示最大的市場佔有率

從治療來看，2022年化療細分市場為主導類型

依地區分類，北美是2022年的主要收入來源

胰臟癌治療與診斷市場-細分分析：

全球胰臟癌治療和診斷市場根據治療類型、診斷、最終用戶和地區進行細分。

市場依治療分為三類：化療。手術、其他治療。在預測期內，預計化療領域將在所研究的市場中發揮重要作用。化療是治療胰臟癌的主要方法，其作用是阻止胰臟癌細胞的生長和分裂，有效地殺死它們。這些化療藥物系統性地發揮作用，透過血流靶向並損害全身的癌細胞。

根據最終用戶，市場分為四類：醫院、診所、實驗室、其他。2022年，就收入佔有率而言，胰臟癌診斷市場主要由醫院部門主導。這種突出地位可歸因於多種因素，包括對個性化藥物的認知提高、可及的醫療服務的增強、患者到醫院就診的增加以及對戰略舉措的日益重視，所有這些都促進了醫院部門的成長。

胰臟癌治療與診斷市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。預計北美將在預測期內主導市場。目標疾病發病率的上升以及營利性和非營利性組織嘗試支持早期疾病識別的增加推動北美地區的擴張。胰臟癌行動網路是支持研究工作並提高人們對該疾病認知的一個著名團體。

胰臟癌治療與診斷市場-競爭格局：

在胰臟癌治療和診斷市場，各公司積極尋求策略，以利用對胰臟癌治療和診斷不斷成長的需求。在胰臟癌治療領域，製藥和生物技術公司參與各種活動，包括新產品發布、夥伴關係、協作和研究計劃。

市場摘要
- 依治療類型分類的胰臟癌治療和診斷市場摘要
- 依診斷分類的胰臟癌治療與診斷市場摘要
- 依最終用戶的胰臟癌治療和診斷市場摘要
- 依國家分類的胰臟癌治療和診斷市場摘要
- 依地區分類的胰臟癌治療和診斷市場摘要
競爭洞察

第3章胰臟癌治療與診斷主要市場趨勢

胰臟癌治療與診斷市場促進因素
- 市場促進因素的影響分析
胰臟癌治療與診斷市場限制
- 市場限制影響分析
胰臟癌治療與診斷市場機會
胰臟癌治療與診斷市場未來趨勢

第4章胰臟癌治療與診斷產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第5章胰臟癌治療與診斷市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第6章胰臟癌治療與診斷市場格局

2022年胰臟癌治療與診斷市佔率分析
細分資料：按主要製造商
- 既有參與者分析
- 新興參與者分析

第7章胰臟癌治療與診斷市場 - 依治療類型

概述
- 依治療類型分類的細分市場佔有率分析
- 標靶治療
- 化療
- 手術
- 其他治療

第8章胰臟癌治療與診斷市場 - 按診斷

概述
- 細分市場佔有率分析（按診斷）
- 影像學
- 活體組織切片
- 超音波內視鏡
- 其他診斷

第9章胰臟癌治療和診斷市場 - 依最終用戶

概述
- 依最終用戶分類的細分市場佔有率分析
- 醫院
- 診所
- 實驗室
- 其他

第10章胰臟癌治療與診斷市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美胰臟癌治療和診斷主要製造商
- 北美市場規模和預測（依國家）
- 北美市場規模和預測（依治療類型）
- 北美市場規模和預測（依診斷）
- 北美市場規模和預測（依最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲胰臟癌治療和診斷主要製造商
- 歐洲市場規模和預測（依國家）
- 歐洲市場規模和預測（依治療類型）
- 歐洲市場規模和預測（依診斷）
- 歐洲市場規模和預測（依最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區（APAC）
- 概述
- 亞太地區胰臟癌治療和診斷主要製造商
- 亞太地區市場規模與預測（依國家）
- 亞太地區市場規模與預測（依治療類型）
- 亞太地區市場規模和預測（依診斷）
- 亞太地區市場規模和預測（依最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲胰臟癌治療和診斷主要製造商
- 拉丁美洲市場規模與預測（依國家）
- 拉丁美洲市場規模與預測（依治療類型）
- 拉丁美洲市場規模和預測（依診斷）
- 拉丁美洲市場規模和預測（依最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲胰臟癌治療和診斷主要製造商
- 中東和非洲市場規模及預測（依國家）
- 中東和非洲市場規模及預測（依治療類型）
- 中東和非洲市場規模及預測（依診斷）
- 中東和非洲市場規模及預測（依最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA的其他地區

第11章主要供應商分析 - 胰臟癌治療與診斷產業

競爭儀表板
公司簡介
- Myriad Genetics Inc.
- Pfizer Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Amgen Inc.
- Viatris Inc.
- Boston Scientific Corporation
- FUJIFILM Holdings Corporation
- Canon Inc.（canon Medical Systems Corporation）

第12章 360 度分析師視角

第13章附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2198

REPORT HIGHLIGHT

Pancreatic Cancer Therapeutics & Diagnostics Market size was valued at USD 2,470.6 Million in 2022, expanding at a CAGR of 5.5% from 2023 to 2030.

Pancreatic cancer therapeutics and diagnostics encompass medical procedures for both the diagnosis and subsequent treatment of pancreatic cancer. Globally, pancreatic cancer stands as a significant contributor to cancer-related fatalities, with the disease burden escalating rapidly. According to the American Cancer Society, the 5-year relative survival rates are approximately 44% for localized cases, 15% for regional cases, and 3% for distant cases. In response, healthcare professionals and authorities are underscoring the need to develop and commercialize precise screening methods to monitor prevalence levels.

Pancreatic Cancer Therapeutics & Diagnostics Market- Market Dynamics

Rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology is expected to propel the market demand

The market growth is driven by factors such as the rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology. The market is poised for significant expansion due to increased research and development initiatives, favorable reimbursement scenarios, and the introduction of innovative products. Notably, in January 2019, scientists at the Van Andel Research Institute introduced a novel blood test (CA19-9 test) that, when combined with an existing test, can detect nearly 70% of pancreatic cancers with a false-positive rate of less than 5%. Additionally, Myriad Genetics Inc. announced in January 2021 that its BRACAnalysis Diagnostic System, used for pancreatic cancer screening, would receive reimbursement from Japan's Ministry of Health, Labour, and Welfare, potentially expanding the patient pool for genetic testing in Japan.Collaborations are also shaping the market positively. In October 2020, Oncolytics Biotech Inc. disclosed a collaboration with Roche and AIO for a phase 1/2 trial evaluating the efficacy of pelareorep and atezolizumab in treating metastatic pancreatic cancer. These developments are anticipated to have a favorable impact on market growth throughout the forecast period.

Pancreatic Cancer Therapeutics & Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global Pancreatic Cancer Therapeutics & Diagnostics Market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2023-2030)

The Cancer Therapeutics & Diagnostics Market is projected to grow at a significant rate due to rising incidence of pancreatic cancer, advancements in molecular biology, drug development, and diagnostic technology

Based on end user, hospital was predicted to show maximum market share in the year 2022

Based on Treatment, chemotherapy segment was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Pancreatic Cancer Therapeutics & Diagnostics Market- Segmentation Analysis:

The Global Pancreatic Cancer Therapeutics & Diagnostics Market is segmented on the basis of Treatment Type, Diagnostic, By End User, and Region.

The market is divided into three categories based on Treatment: Chemotherapy. Surgery, Other Treatments. Over the forecast period, it is anticipated that the chemotherapy segment will play a significant role in the studied market. Chemotherapy stands as a primary method of treating pancreatic cancer, functioning by impeding the growth and division of pancreatic cancer cells, effectively killing them. These chemotherapy drugs operate systemically, traveling through the bloodstream to target and damage cancer cells throughout the entire body.

The market is divided into four categories based on End User: Hospitals, Clinics, Laboratories, Others. In 2022, the pancreatic cancer diagnostics market was predominantly led by the hospitals segment in terms of revenue share. This prominence can be attributed to several factors, including heightened awareness of personalized medicines, enhancements in accessible healthcare services, an uptick in patient visits to hospitals, and an increasing emphasis on strategic initiatives, all of which are bolstering the growth of the hospital segment.

Pancreatic Cancer Therapeutics & Diagnostics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The target illness's rising incidence and the rise in for-profit and nonprofit organizations' attempts to support early disease identification are driving the expansion of the North American area. One well-known group that supports research efforts and raises awareness of the disease is the Pancreatic Cancer Action Network.

Pancreatic Cancer Therapeutics & Diagnostics Market- Competitive Landscape:

In the pancreatic cancer therapeutic & diagnostic market, companies are actively pursuing strategies to capitalize on the increasing demand for Pancreatic Cancer Therapeutics & Diagnostics. In the field of pancreatic cancer therapeutics, pharmaceutical and biotechnology companies are involved in various activities, including new product launches, partnerships, collaborations, and research initiatives.

Recent Developments:

In January 2023, the evaluation of the radiotracer, 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46, in pancreatic cancer imaging through a clinical study was released by Mayo Clinic.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET KEY PLAYERS

Myriad Genetics Inc.
Pfizer Inc.
Novartis AG
Bristol-Myers Squibb Company
AstraZeneca PLC
Amgen Inc.
Viatris Inc.
Boston Scientific Corporation
FUJIFILM Holdings Corporation
Canon Inc. (canon Medical Systems Corporation)

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY TREATMENT TYPE

Targeted Therapies
Chemotherapy
Surgery
Other Treatments

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY DIAGNOSTIC

Imaging
Biopsy
Endoscopic Ultrasound
Other Diagnostics

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY END USER

Hospitals
Clinics
Laboratories
Others

GLOBAL PANCREATIC CANCER THERAPEUTICS & DIAGNOSTICS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Pancreatic Cancer Therapeutics & Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Treatment Type
- 2.1.2. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Diagnostics
- 2.1.3. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by End Users
- 2.1.4. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Country
- 2.1.5. Pancreatic Cancer Therapeutics & Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. Pancreatic Cancer Therapeutics & Diagnostics Key Market Trends

3.1. Pancreatic Cancer Therapeutics & Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Pancreatic Cancer Therapeutics & Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Pancreatic Cancer Therapeutics & Diagnostics Market Opportunities
3.4. Pancreatic Cancer Therapeutics & Diagnostics Market Future Trends

4. Pancreatic Cancer Therapeutics & Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Pancreatic Cancer Therapeutics & Diagnostics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Pancreatic Cancer Therapeutics & Diagnostics Market Landscape

6.1. Pancreatic Cancer Therapeutics & Diagnostics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Pancreatic Cancer Therapeutics & Diagnostics Market - By Treatment Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
- 7.1.2. Targeted Therapies
- 7.1.3. Chemotherapy
- 7.1.4. Surgery
- 7.1.5. Other Treatments

8. Pancreatic Cancer Therapeutics & Diagnostics Market - By Diagnostics

8.1. Overview
- 8.1.1. Segment Share Analysis, By Diagnostics, 2022 & 2030 (%)
- 8.1.2. Imaging
- 8.1.3. Biopsy
- 8.1.4. Endoscopic Ultrasound
- 8.1.5. Other Diagnostics

9. Pancreatic Cancer Therapeutics & Diagnostics Market - By End Users

9.1. Overview
- 9.1.1. Segment Share Analysis, By End Users, 2022 & 2030 (%)
- 9.1.2. Hospitals
- 9.1.3. Clinics
- 9.1.4. Laboratories
- 9.1.5. Others

10. Pancreatic Cancer Therapeutics & Diagnostics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Pancreatic Cancer Therapeutics & Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Diagnostics, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End Users, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Pancreatic Cancer Therapeutics & Diagnostics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Myriad Genetics Inc.
- 11.2.2. Pfizer Inc.
- 11.2.3. Novartis AG
- 11.2.4. Bristol-Myers Squibb Company
- 11.2.5. AstraZeneca PLC
- 11.2.6. Amgen Inc.
- 11.2.7. Viatris Inc.
- 11.2.8. Boston Scientific Corporation
- 11.2.9. FUJIFILM Holdings Corporation
- 11.2.10. Canon Inc. (canon Medical Systems Corporation)

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Treatment Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Treatment Type
TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type 2018-2030 (USD Million)
TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Diagnostics Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Diagnostics
TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics 2018-2030 (USD Million)
TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: End Users Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by End Users
TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users 2018-2030 (USD Million)
TABLE Pancreatic Cancer Therapeutics & Diagnostics Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Pancreatic Cancer Therapeutics & Diagnostics Market, by Region 2018-2030 (USD Million)
TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
TABLE North America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
TABLE Europe Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
TABLE Asia Pacific Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
TABLE Latin America Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)
TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Treatment Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by Diagnostics, 2018-2030 (USD Million)
TABLE Middle East and Africa Pancreatic Cancer Therapeutics & Diagnostics Market, by End Users, 2018-2030 (USD Million)